Drug Profile
Helicore
Alternative Names: HelicoreLatest Information Update: 28 Nov 2006
Price :
$50
*
At a glance
- Originator Novavax
- Class Anti-infectives
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 23 Dec 1998 Preclinical development for Helicobacter infections in USA (PO)
- 03 Dec 1997 New profile
- 03 Dec 1997 Phase-II clinical trials for Helicobacter infections in USA (PO)